Kathleen I Pritchard

Years Active: 2019-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela J Goodwin, Roanne J Segal, Michael Vallis, Jennifer A Ligibel, Gregory R Pond, André Robidoux, Brian Findlay, Julie R Gralow, Som D Mukherjee, Mark Levine, Kathleen I Pritchard
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer. NPJ breast cancer 6 (2020)
Mitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, Carol Townsley, Dave Warr, Christine Elser, Eitan Amir, Philippe L Bedard, Lakshmi Rao, Vuk Stambolic, Srikala S Sridhar, Pamela J Goodwin, David W Cescon
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study. NPJ breast cancer 6 (2020)
Joseph A Sparano, Robert J Gray, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Matthew P Goetz, John A Olson, Tracy Lively, Sunil S Badve, Thomas J Saphner, Lynne I Wagner, Timothy J Whelan, Matthew J Ellis, Soonmyung Paik, William C Wood, Maccon M Keane, Henry L Gomez Moreno, Pavan S Reddy, Timothy F Goggins, Ingrid A Mayer, Adam M Brufsky, Deborah L Toppmeyer, Virginia G Kaklamani, Jeffrey L Berenberg, Jeffrey Abrams, George W Sledge
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. The New England journal of medicine 380 (25) (2019)

Kathleen I Pritchard.css-eqlu8i{font-size:small;padding-left:4px;}